Zura Bio Limited (ZURA) short interest & options flow
NASDAQZura Bio arrives at its August 14 earnings event with an unusually sharp divide between analyst optimism and short-seller conviction — the tension between those two forces is what makes this print matter. The analyst setup is the most striking element heading into the release. Wedbush lifted its target from $15 to $22 on August 12, while Guggenheim moved from $15 to $20 on the same…
- Market cap
- $393M
- Next earnings
- 13 Nov 2026
Key data as of 9 Nov 2026

ZURA news and analysis
RSSNo long-form analysis yet for ZURA. Pulse alerts and the live data picture are available on ORTEX.
Open ZURA on ORTEX →Want the live picture for ZURA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZURA — free to start on ORTEX.
Sign up for free →Open ZURA on ORTEX